Ligandrol (LGD-4033)

  • Research-grade selective androgen receptor modulator (SARM)
  • 99%+ purity — independently HPLC tested
  • Phase I human trial: 1.21 kg lean mass gain at 1 mg/day in 21 days
  • ~10:1 anabolic-to-androgenic ratio
  • Active Phase II programme (Viking Therapeutics VK5211)
  • Free next-day UK delivery & international shipping
  • Manufactured in a GMP-certified UK facility
  • Certificate of Analysis included

£49.99

Buy Now
Compare

Buy Ligandrol (LGD-4033) UK from sarms.co.uk. Our LGD-4033 stock is HPLC-tested and batch checked for consistent research-grade quality with fast UK shipping.

What Is LGD-4033 (Ligandrol)?

LGD-4033 (Ligandrol) is an investigational compound studied in androgen receptor pathway research. This page provides a practical research reference overview with mechanism context, evidence limits, handling notes, and batch verification standards.

Compound Profile

Name LGD-4033 (Ligandrol)
CAS 1165910-22-4
Formula C14H12F6N2O
Molecular Weight 338.25 g/mol
Category Investigational non-steroidal AR-active compound
PubChem 44137675

What is lgd-4033 ligandrol is a common query used by researchers comparing AR-pathway references and trial-history summaries.

How Does LGD-4033 Work?

Published work describes LGD-4033 as an androgen receptor ligand studied for selective pathway behaviour in preclinical and early clinical settings. This page is technical reference content, not therapeutic guidance.

Researchers often compare lgd-4033 vs rad-140 research when assessing selectivity models, endpoint design, and evidence maturity.

What Does Current Research Say?

  • Clinical and preclinical literature includes body-composition and endocrine endpoint discussions.
  • Evidence quality varies by cohort, duration, and endpoint type.
  • No broad consumer therapeutic approval exists.
  • Interpretation should prioritize study design and method quality.

Typical search intent includes lgd-4033 dosage research use and lgd-4033 cycle length research phrasing, which should be read as literature context rather than user instruction.

Batch Verification & Quality Controls

  • Analytical method: HPLC (with supporting documentation)
  • Batch records: lot-specific QC trail available
  • Identity checks: method-linked reporting by batch
  • Documentation: COA available for verification

Teams commonly request hplc tested lgd-4033 evidence before assay planning and sample intake.

Storage & Handling

LGD-4033 storage and handling should follow lab SOP standards: sealed storage, light/moisture protection, and documented chain-of-custody controls.

LGD-4033 FAQ

This lgd-4033 faq section addresses high-intent technical questions before protocol design.

Is LGD-4033 the same as Ligandrol?

Yes. LGD-4033 and Ligandrol refer to the same investigational compound in research contexts.

Is LGD-4033 approved for human use?

No. It is investigational and supplied for laboratory and analytical use only.

Can batch quality be verified?

Yes. COA and batch-linked documentation are available.

Why is this page research-focused?

Because this product is intended for analytical and laboratory workflows, not therapeutic use.

Related Research Compounds

Common search variants such as lgd-4033 for sale and vk5211 are handled here in strict research-reference context.

References

  1. Basaria S et al. early LGD-4033 clinical literature.
  2. Viking Therapeutics pathway reporting for VK5211 lineage context.
  3. WADA guidance for SARMs/investigational compounds.
  4. Regulatory safety communications on unapproved SARMs-type products.

Disclaimers

  • For laboratory and analytical research use only
  • Not for human consumption
  • Not a medicine, supplement, or food product

Readers looking to buy lgd-4033 can use this page as a research-reference summary before making any purchasing decisions.

Weight 4.2 kg
Dimensions 1 × 2 × 3 cm

Reviews

There are no reviews yet

Be the first to review “Ligandrol (LGD-4033)”